ADC • antibody-targeted drug delivery • cancer therapy • payload • site-specific conjugation"Globally, with new payloads and evolving linkers, taking a holistic approach to the development of antibody-drug conjugates remains paramount.
No takes yet. Share an insight, caveat, or question.
Vankemmelbeke et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: